Facebook
X
LinkedIn
Forward23rd Annual International Ultmann Chicago Lymphoma Symposium
Chicago, IL US
April 10, 2026 to April 11, 2026
The 23rd International Ultmann Chicago Lymphoma Symposium (IUCLS) is a continuation of an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
The goal of this educational activity is to facilitate a forum for physicians, nurses, researchers, and other healthcare professionals to discuss biologic, diagnostic, and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma.
This event gives opportunities for providers to explore vital information on clinical updates and research in order to ensure they are using the latest treatment options in their practice.
Learn more at the symposium website!
Target Audience
The target audience for this symposium is practicing oncologists, hematologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and the other health professionals interested in the treatment and diagnosis of lymphoma.
Learning Objectives
After participating in the activity, participants should be better able to:
- Evaluate safety and efficacy results from clinical trials investigating approved and novel treatment strategies being studied in patients with indolent and aggressive subtypes of B-cell and T-cell non-Hodgkin lymphoma;
- Develop strategies to optimize the selection and sequencing of therapeutic approaches for patients with newly diagnosed and relapsed/refractory Hodgkin lymphoma;
- Assess multiple various patient and disease-related factors and their impact on therapeutic decisions for patients with newly diagnosed and previously treated CLL/SLL;
- Cultivate strategies to enhance patient, caregiver, and healthcare provider communication in order to enhance the outcomes and survival of patients with lymphoma.
You may also be interested in
Westin Chicago River North
320 N Dearborn St
Chicago, IL
60654
United States
WANT TO KNOW MORE?
Learn more about the program by visiting the symposium website! For questions, contact the Conference Secretariat via e-mail.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at [email protected].
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
SYMPOSIUM CO-CHAIRS
Sonali M. Smith, MD, FASCO
Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
University of Chicago
Andrew Evens, DO, MBS, MSc
Deputy Director for Clinical Services, Rutgers Cancer Institute
Associate Vice Chancellor, Clinical Innovation & Data Analytics, Rutgers Health
Oncology Lead for RWJBarnabas Health Medical Group, and System Director of Medical Oncology, RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
University of Chicago
Andrew Evens, DO, MBS, MSc
Deputy Director for Clinical Services, Rutgers Cancer Institute
Associate Vice Chancellor, Clinical Innovation & Data Analytics, Rutgers Health
Oncology Lead for RWJBarnabas Health Medical Group, and System Director of Medical Oncology, RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Timothy S. Fenske, MD
Medical Director of Immune Effector Cell Therapy
Sarah Cannon Transplant & Cellular Therapy
Program at Methodist Hospital
San Antonio, Texas
Medical Director of Immune Effector Cell Therapy
Sarah Cannon Transplant & Cellular Therapy
Program at Methodist Hospital
San Antonio, Texas
Neha Mehta-Shah, MD, MSCI
Associate Professor
Washington University School of Medicine in St. Louis
St. Louis, Missouri
For more information, visit the symposium website.
Associate Professor
Washington University School of Medicine in St. Louis
St. Louis, Missouri
For more information, visit the symposium website.
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This live activity is designated for a maximum of 12 continuing nursing education units.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
REGISTRATION: Click the button below for complete registration information and to register. Early-bird rates are available through March 17, 2026. For questions or concerns, please contact the Conference Secretariat via e-mail.
Symposium and Interprofessional Session
| Profession Type | Early Bird Fee | After Early Bird Fee |
|---|---|---|
| Physician/PharmD/PhD | $350 | $400 |
| Nurse/OHP | $175 | $200 |
| Fellow/Resident/Student | $150 | $200 |
| Pharma Industry/Representative (Non-Exhibitor) | $625 | $775 |
Symposium ONLY
| Profession Type | Early Bird Fee | After Early Bird Fee |
|---|---|---|
| Physician/PharmD/PhD | $300 | $350 |
| Nurse/OHP | $150 | $200 |
| Fellow/Resident/Student | $125 | $150 |
| Pharma Industry/Representative (Non-Exhibitor) | $475 | $525 |
Interprofessional Session ONLY
| Profession Type | Early Bird Fee | After Early Bird Fee |
|---|---|---|
| Physician/PharmD/PhD | $125 | $175 |
| Nurse/OHP | $100 | $125 |
| Fellow/Resident/Student | $100 | $125 |
| Pharma Industry/Representative (Non-Exhibitor) | $175 | $225 |
CANCELLATION POLICY: See website for complete information.
CLAIMING CREDIT: After the conference, create or log into your UChicago CME account and enter the access code to unlock the credit claiming process.
Please note: The credit claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.